
Novel therapeutic agents that target the zzso growth factor zzso zzso constitute an important addition to the therapeutic zzso for the treatment of zzso zzso zzso agents currently approved by the zzso Food and Drug Administration include zzso a zzso zzso for the treatment of zzso zzso and the zzso zzso zzso zzso inhibitor zzso zzso for the treatment of zzso cell lung cancer zzso and pancreatic zzso Approval of the zzso zzso for zzso recently was zzso Although both classes of zzso agents target the same zzso substantial distinctions regarding their mechanism significantly affect dosing requirements, toxicity profiles, and their use as combination zzso 

